A delegation led by the Guiyang Municipal Committee of the Jiusan Society visited and conducted a research tour at our company.


2023-03-29


Vice Chairman Han Lihua listened carefully to General Manager He Yongyin’s report on the company’s business operations and the progress of its capacity expansion and production construction projects. He expressed full support for the company’s future development plans, market strategies, and employment needs. He also engaged in exchanges and provided guidance on the challenges and issues the company is facing, emphasizing that while pursuing growth, the company must maintain strict control over both drug safety and production safety.

March 29, 2023 Up Noon, Guiyang Municipal Committee of the 93rd Society Vice Chair Han Lihua and his delegation Leader Attend in person My company Conduct field research

Vice Chair Han Lihua Listened carefully to General Manager He Yongyin to Enterprise Management Situation Expand capacity and build production Project Progress Report to the company Not yet Come. Development Planning, market layout, and employment needs are both given full consideration. Certainly; To the company Facing The difficulties and problems To carry out Exchange Guidance Emphasize Enterprise While pursuing development, we must strictly ensure drug safety and production safety.

Vice Chair Han Lihua once again gave a presentation to our company. “The spirit of the 20th National Congress,” and propose Member Member units should actively offer advice and suggestions, reflect public sentiment and opinions, and participate more in the society’s activities, fully fulfilling their expectations of corporate social responsibility.

The guidance and care from our leaders are a form of recognition and encouragement. Finder Pharmaceutical will surely respond positively to the call, fulfill our corporate responsibilities, demonstrate social commitment, and further enhance the company’s management with greater precision and standardization. , achieve higher-quality and more efficient development, and take Finder Pharmaceutical to the next level.


Relevant documents


Related News